Health Catalyst, Inc.
HCAT· Nasdaq
Health Catalyst, Inc.
- Last sale
- Oct 1, 2026 · -1.72%
- Market cap
- $128.69M
- 75.26M shares
- Filings
- 931
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $311,136,000 | reported | |
| FY 2024 | 2024-12-31 | $306,584,000 | reported | |
| FY 2023 | 2023-12-31 | $295,938,000 | reported | |
| FY 2022 | 2022-12-31 | $276,236,000 | reported | |
| FY 2021 | 2021-12-31 | $241,926,000 | reported | |
| FY 2020 | 2020-12-31 | $188,845,000 | reported | |
| FY 2019 | 2019-12-31 | $154,941,000 | reported | |
| FY 2018 | 2018-12-31 | $112,574,000 | reported | |
| FY 2017 | 2017-12-31 | $73,081,000 | reported |
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR
